ACTRN12617000636358
Completed
未知
Evaluation of adipose-derived mesenchymal stem cells for the treatment of chronic lower back discogenic pain - a prospective, case series pilot study
Magellan Stem Cells0 sites10 target enrollmentMay 2, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ower Back Pain
- Sponsor
- Magellan Stem Cells
- Enrollment
- 10
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) 18 years or older
- •2\) Severe low back pain
- •3\) Failure with 3 months of conservative back pain care.
Exclusion Criteria
- •1\.Age \<18yrs
- •2\.Breastfeeding (accepted contra\-indication as no safety data on this population).
- •3\.Blood disorder (accepted contra\-indication as no safety data on this population)
- •4\.Anti\-coagulant therapy that cannot safely be ceased.
- •5\.History of malignancy within 10years.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The evaluation of mesenchymal stem cells in the treatment of arthritisArthritisACTRN12617000638336Melbourne Stem Cell Centre200
Recruiting
Phase 1/2
Adipose-derived mesenchymal stem cells as local treatment of ulcerative colitis2024-518643-38-00Region Midtjylland16
Completed
Not Applicable
Osteoarthritis stem cell therapyKnee osteoarthritisMusculoskeletal DiseasesISRCTN13337022Specialty Hospital St. Catherine32
Completed
Early Phase 1
Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune UrticariaUrticariaAutoimmune DiseasesImmune System DiseasesSkin DiseasesNCT02824393Celal Bayar University10
Unknown
Not Applicable
Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem CellsMesenchymal Stem CellsChronic Kidney DiseasesRenal Interstitial FibrosisNCT03321942The Affiliated Hospital of Xuzhou Medical University100